<unk>  is licensed for the short-term relief of anxiety, although whether the purported antianxiety effects of<unk>  are separable from its sedative effects is not known. Its effectiveness as a selective agent for the treatment of anxiety has not been proven in humans, and is not used as often as the benzodiazepines for this purpose.<unk>  is available in 200- and 400-mg tablets for oral administration. It is also a component of the combination drug Equagesic (discontinued in the UK in 2002), acting as a muscle relaxant.<unk> , like barbiturates, possesses an analgesic/anesthetic potential. It is also found as a component of the combination analgesic Stopayne capsules (along with paracetamol (acetaminophen), caffeine, and codeine phosphate). right
Meprobamate
Felbamate
Lamotrigine
Cenobamate
Topiramate
Disulfiram
Retigabine
Tiagabine